Table 2.
Patient | Gene | Transcript ID | Nucleotide Variant | Protein Variant | dbSNP | Inheri Tance |
Frequency | ACMG Classification | Prediction Tools | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
gnomAD Exomes | 500 Greek Exomes | SIFT | PolyPhen2 | Mutation Taster | CADD | GERP | ||||||||
1 | BMP4 | NM_001202.4 | c.124G > C | p.[Ala42Pro;=] | rs140920120 | M | 0.000283 | HTZ:0.002 | VUS | B | LP | B | 22.6 | 5.19 |
HMZ: 0 | (BP4, PS3) | |||||||||||||
GNRH1 | NM_000825.3 | c.217C > T | p.[Arg73Ter;=] | rs375970738 | P | 0.00000805 | 0 | LP | - | - | - | 14.98 | 4.91 | |
(PVS1, PM2) | ||||||||||||||
SRA1 | NM_001035235.4 | c.94C > G | p.[Gln32Glu;=] | rs35610885 | M | 0.00715 | HTZ: 0.008 | VUS | P | LP | DC | 27.6 | 5.01 | |
HMZ: 0 | (BP4, PP5) | |||||||||||||
2 | SOX9 | NM_000346.4 | c.283G > A | p.[Val95Ile;=] | Novel | M | NA | 0 | VUS | B | LP | DC | 23.3 | 4.24 |
(PM2, BP4) | ||||||||||||||
HS6ST1 | NM_004807.3 | c.917G > A | p.[Arg306Gln;=] | rs201307896 | M | 0.000706 | 0 | P | B | LP | DC | 29.9 | 4.78 | |
(PS3, PM2, PM5, PP5, PP3) | ||||||||||||||
IL17RD | NM_017563.5 | c.1696C > T | p.[Pro566Ser;=] | rs61742267 | M | 0.0144 | HTZ: 0.028 | VUS | B | LP | DC | 22.6 | 5.64 | |
HMZ: 0 | (PM5, BP4) |
Abbreviations: dbSNP = database Single Nucleotide Polymorphism, gnomAD = Genome Aggregation Database, ACMG = American College of Medical Genetics, SIFT = Sorting Intolerant From Tolerant, Polyphen2 = Polymorphism Phenotyping v2, CADD = Combined Annotation-Dependent Depletion, GERP = Genomic Evolutionary Rate Profiling, M = Maternal, P = Paternal, NA: not annotated, VUS = Variant of Uncertain Significance, B:Benign, P = Pathogenic, LP = Likely Pathogenic, DC = Disease Causing, PD = Probably Damaging, HTZ = Heterozygous, HMZ = Homozygous.